International Patents and International Harmonization

Increasingly global markets have rewarded biopharmaceutical companies with operations outside the United States and Europe with ample opportunities to expand successfully into new marketplaces around the world. At the same time, innovative companies in the biotechnology and pharmaceutical industries depend heavily on the protection of their intellectual property. In today's international markets, biopharmaceutical companies still face rampant piracy and counterfeiting of patented products. Since the establishment of the World Trade Organization (WTO) in 1995, important progress has been made in achieving better international harmonization of patent laws; however, many challenges for innovative biopharmaceutical companies remain, and new obstacles continue to emerge.

View Full Article